The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients

Expert Opinion on Biological Therapy

Volumn 12, Issue SUPPL. 1, 2012, Pages

  Mouliere, Florent ^a   Thierry, Alain R ^a,b  

^a U896 Inserm CRLC Val d'Aurelle   (France)

^b INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

Circulating DNA; Colorectal cancer; Mechanism of release; Microenvironment; Point mutation

Indexed keywords

B RAF KINASE; DNA; GENOMIC DNA; K RAS PROTEIN;

CANCER PATIENT; CELL SIZE; CELLS; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONFERENCE PAPER; DNA FRAGMENTATION; GENE MUTATION; HUMAN; NONHUMAN; POINT MUTATION; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

COLORECTAL NEOPLASMS; DNA; GENES, RAS; HUMANS; PROTO-ONCOGENE PROTEINS B-RAF; TUMOR MICROENVIRONMENT;

EID: 84861438263     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.688023     Document Type: Conference Paper

References (26)

1. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11(6):426-37
2. Jung K, Fleischhacker M, Rabien A. Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature. Clin Chim Acta 2010;411(21-22):1611-24
3. Frattini M, Gallino G, Signoroni S, et al. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. Cancer Lett 2008;263(2):170-81
4. Gormally E, Hainaut P, Caboux E, et al. Amount of DNA in plasma and cancer risk: a prospective study. Int J Cancer 2004;111(5):746-9 (Pubitemid 39062898)
5. Wang BG, Huang HY, Chen YC, et al. Increased plasma DNA integrity in cancer patients. Cancer Res 2003;63(14):3966-8 (Pubitemid 36917913)
6. Stroun M, Lyautey J, Lederrey C, et al. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001;313(1-2):139-42 (Pubitemid 33016703)
7. Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61(4):1659-65 (Pubitemid 34292602)
8. Holdenrieder S, Holubec L Jr, Topolcan O, et al. Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy. Anticancer Res 2005;25(3A):1795-801 (Pubitemid 40896805)
9. Smith G, Carey FA, Beattie J, et al. Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 2002;99(14):9433-8 (Pubitemid 34764631)
10. Morlan J, Baker J, Sinicropi D. Mutation detection by real-time PCR: a simple, robust and highly selective method. PLoS One 2009;4(2):e4584
11. Mouliere F, Gongora C, Guedj AS, et al. Detection of high mutation load in circulating DNA from colorectal cancer patients with KRAS and BRAF point mutation enables the non-invasive molecular analysis of tumors. Cancer Research, in press
12. Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008;14(9):985-90
13. Leary RJ, Kinde I, Diehl F, et al. Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med 2010;2(20):20ra14
14. Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 2005;102(45):16368-73 (Pubitemid 41688920)
15. Holdhoff M, Schmidt K, Donehower R, Diaz LA Jr. Analysis of circulating tumor DNA to confirm somatic KRAS mutations. J Natl Cancer Inst 2009;101(18):1284-5
16. Taniguchi K, Uchida J, Nishino K, et al. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin Cancer Res 2011;17(24):7808-15
17. Chan KC, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50(1):88-92 (Pubitemid 38125703)
18. Umetani N, Giuliano AE, Hiramatsu SH, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 2006;24(26):4270-6 (Pubitemid 46630784)
19. Deligezer U, Eralp Y, Akisik EE, et al. Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy. Clin Chem Lab Med 2008;46(3):311-17 (Pubitemid 351317779)
20. Thierry AR, Mouliere F, Gongora C, et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res 2010;38:6159-75
21. Mouliere F, Robert B, Arnau Peyrotte E, et al. High fragmentation characterizes tumour-derived circulating DNA. PLoS One 2011;6(9):e23418
22. Thierry AR, Norris V, Molina F, Schmutz M. Lipoplex nanostructures reveal a general self-organization of nucleic acids. Biochim Biophys Acta 2009;1790(5):385-94
23. Gahan PB, Stroun M. The virtosome-a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct 2010;28(7):529-38
24. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003;200(4):429-47 (Pubitemid 36818244)
25. West NP, Dattani M, McShane P, et al. The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. BJC 2010;102:1519-23
26. Choi JJ, Reich CF III, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 2005;115(1):55-62 (Pubitemid 40593291)